GlobeNewswire by notified

Standard Lithium Files Technical Report for the South West Arkansas Project

Share

EL DORADO, Ark., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium company, announces that the Preliminary Feasibility Study for the South West Arkansas Project (the “Report”), as announced on August 8, 2023, has been filed.

The Report is available for review under the Company’s profile on SEDAR+ at www.sedar.com and on the Company’s website at www.standardlithium.com/projects/arkansas-smackover. For highlights of this Report, please refer to the Company’s press release dated 8 August 2023.

About the South West Arkansas Project

The South West Arkansas Project (“SWA Project”) is located approximately 15 miles west of the City of Magnolia in southwestern Arkansas. The SWA Project’s Indicated and Inferred Mineral Resource of 1.4 Mt and 0.4 Mt lithium carbonate equivalent, respectively, has some of the highest reported lithium brine concentrations in North America, averaging above 400 mg/L. The Preliminary Feasibility Study demonstrates robust economics, assuming production of at least 30,000 tonnes per year of battery-quality lithium hydroxide beginning in 2027 over a 20-plus year operating life.

The Company anticipates completing a FEED and Definitive Feasibility Study for the SWA Project in 2024 and beginning construction in 2025. Commercial production is expected in 2027, subject to continuing project definition, due diligence, project financing and receipt of future feasibility studies.

About Standard Lithium Ltd.

Standard Lithium is a leading near-commercial lithium development company focused on the sustainable development of a portfolio of lithium-brine bearing properties in the United States. The Company prioritizes brine projects characterized by high-grade resources, robust infrastructure, skilled labor, and streamlined permitting. The Company aims to achieve sustainable, commercial-scale lithium production via the application of a scalable and fully-integrated Direct Lithium Extraction (“DLE”) and purification process. The Company’s signature projects, the Phase 1A Project and the South West Arkansas Project, are located on the Smackover Formation in southern Arkansas near the Louisiana state line, a region with a long-standing and established brine processing industry. The Company has also identified a number of highly prospective lithium brine project areas in the Smackover Formation in East Texas and began an extensive brine leasing program in the key project areas.  In addition, the Company has an interest in certain mineral leases located in the Mojave Desert in San Bernardino County, California.

Standard Lithium trades on both the TSX Venture Exchange and the NYSE American under the symbol “SLI”; and on the Frankfurt Stock Exchange under the symbol “S5L”. Please visit the Company’s website at www.standardlithium.com.

Qualified Person

Steve Ross, P.Geol., a qualified person as defined by National Instrument 43-101, and Vice President Resource Development for the Company, has reviewed and approved the relevant scientific and technical information in this news release.

Twitter: @standardlithium
LinkedIn: https://www.linkedin.com/company/standard-lithium/

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain certain “Forward-Looking Statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. When used in this news release, the words “anticipate”, “believe”, “estimate”, “expect”, “target, “plan”, “forecast”, “may”, “schedule” and other similar words or expressions identify forward-looking statements or information. These forward-looking statements or information may relate to intended development timelines, future prices of commodities, accuracy of mineral or resource exploration activity, reserves or resources, regulatory or government requirements or approvals, the reliability of third party information, continued access to mineral properties or infrastructure, fluctuations in the market for lithium and its derivatives, changes in exploration costs and government regulation in Canada and the United States, and other factors or information. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

SkiStar Year-End Report September 2022-August 20233.10.2023 07:00:00 CEST | Press release

STABLE GROWTH IN TURNOVER – HIGH BOOKING RATE FOR THE WINTER Fourth Quarter Net sales for the fourth quarter increased by SEK 121 million (54 percent) to SEK 345 (224) million.Operating profit for the fourth quarter amounted to SEK -230 (-265) million, an improvement of SEK 35 million (13 percent).Capital gains from exploitation operations included SEK 63 (-4) million.Earnings per share before and after dilution amounted to SEK -2.64 (-2.70). Full Year Net sales for the full year were SEK 4,281 (4,092) million, an increase of SEK 189 million (5 percent).Operating profit for the full year decreased by SEK 280 million (32 percent) to SEK 604 (884) million.Earnings per share before and after dilution amounted to SEK 5.13 (8.50), a decrease of 40 percent.Capital gains from Property Development and Exploitation operations included SEK 75 (57) million.The Board proposes a dividend of SEK 2.60 (3.00) per share, totalling SEK 204 (235) million. The dividend represents 51 (36) percent of the Gr

NMD Pharma to present NMD670 clinical data from a Phase I/IIa trial in myasthenia gravis at the 28th International Annual Congress of the World Muscle Society3.10.2023 07:00:00 CEST | Press release

NMD Pharma to present NMD670 clinical data from a Phase I/IIa trial in myasthenia gravis at the 28th International Annual Congress of the World Muscle Society NMD Pharma will show the first ever clinical proof-of-mechanism for the novel concept of ClC-1 inhibition with NMD670 in treatment of neuromuscular diseases demonstrated in patients with myasthenia gravis The data provides clinical validation of the ability of CIC-1 inhibition to restore neuromuscular function leading to clinically meaningful effects with a single dose of NMD670This data has been instrumental in the design ofthe recently initiated Phase II clinical trial of NMD670 in patients with type 3 spinal muscular atrophy Aarhus, Denmark,3October2023 – NMD Pharma A/S, a clinical-stage biotech company developing first-in-class, small molecule ClC-1 inhibitors directly targeting muscle function within neuromuscular disorders, today announces that it will present data from a Phase I/IIa clinical trial of NMD670 in patients wit

“BEYOND THE EXPECTED”: SIKA LAUNCHES NEW GROWTH STRATEGY 2028 WITH MORE AMBITIOUS TARGETS3.10.2023 07:00:00 CEST | Press release

Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules “BEYOND THE EXPECTED”: SIKA LAUNCHES NEW GROWTH STRATEGY 2028 WITH MORE AMBITIOUS TARGETS At today’s Capital Markets Day in Zurich, Sika presents its new Strategy 2028, “Beyond the Expected”, which builds on the company’s successful growth model. The roadmap leverages on Sika’s strong market position and innovation power and sets the course for an even stronger performance in the years to come. The annual growth target will be lifted to 6-9% in local currencies and profitability target will be increased to an EBITDA margin of 20-23%. The new growth strategy is based on the four pillars market penetration, innovation & sustainability, acquisitions, as well as people & culture and includes a balanced set of financial and non-financial targets. Furthermore, Sika reports a strong sales growth year to date (January to August 2023) of +12.2%. Thomas Hasler, CEO: “Beyond the Expected – that’s what Sika sta

SkiStar Bokslutskommuniké september 2022-augusti 20233.10.2023 07:00:00 CEST | Pressemelding

STABIL OMSÄTTNINGSTILLVÄXT – HÖGT BOKNINGSLÄGE TILL VINTERN Fjärde kvartalet Nettoomsättningen för det fjärde kvartalet ökade med 121 MSEK, 54 procent, till 345 MSEK (224).Rörelseresultatet för det fjärde kvartalet uppgick till -230 MSEK (-265), vilket är en förbättring med 35 MSEK, 13 procent.Reavinster från exploateringsverksamheten ingick med 63 MSEK (-4).Resultat per aktie före och efter utspädning uppgick till -2,64 SEK (-2,70). Helåret Nettoomsättningen för helåret ökade med 189 MSEK, 5 procent, till 4 281 MSEK (4 092).Rörelseresultatet för helåret minskade med 280 MSEK, 32 procent, till 604 MSEK (884).Resultat per aktie före och efter utspädning uppgick till 5,13 SEK (8,50), vilket är en minskning med 40 procent.Reavinster från Fastighetsutvecklings- och exploateringsverksamheten ingick med 75 MSEK (57).Styrelsen föreslår en vinstutdelning om 2:60 SEK (3:00) per aktie, motsvarande totalt 204 MSEK (235). Utdelningen utgör 51 procent (36) av koncernens vinst efter skatt. Väsentlig

Technicolor Creative Studios: Business Update and First Half 2023 Financial Results2.10.2023 21:55:38 CEST | Press release

CORPORATE PRESS RELEASE Technicolor Creative StudiosBusiness Update and First Half 2023Financial Results PARIS (FRANCE), OCTOBER 2,2023 – Technicolor Creative Studios (Euronext Paris: TCHCS) (the “Company”) today provided business update and announced its first half 2023 financial results1. Acceleration of the transformation plan to drive the recovery of the business Impact of strikes in Hollywood andunfavourable macroeconomic environment led to reduction of activity withlower financial and operational performancefor thefirst half 2023Renewed confidence from majority shareholders and lenders with:An additional €30 million of new money injection to address liquidity needs A proposed tender offer (“offre publique d’achat simplifiée”)at a price of 1,63 euro per share, dividends included,to beinitiated by a large majority of shareholders and lenders (holding 94,82% of the capital) acting in concert in view of proceeding to a mandatory squeeze outto achieve delisting of Technicolor Creative